Point32Health prior authorization criteria
Documentation packets and P2P preparation by drug—for prescribers and PA staff. Verify the current member-specific payer criteria and timing before submission.
Point32Health reviews prior-authorization requests against its published medical policies — diagnosis with ICD-10 code, documented step-therapy history, and prescriber attestation of medical necessity. The applicable product, plan terms, request type, urgency, and governing law determine the decision and appeal clocks. Confirm both in the current member-specific source and denial notice. Criteria by drug appear below.
Prior authorization criteria by drug
Each page covers Point32Health's submission criteria, the documentation packet, and peer-to-peer prep for that drug.
- Adalimumab at Point32Health →
- Aflibercept at Point32Health →
- Apixaban at Point32Health →
- Atezolizumab at Point32Health →
- Atogepant at Point32Health →
- Benralizumab at Point32Health →
- Bevacizumab at Point32Health →
- Bictegravir at Point32Health →
- Buprenorphine at Point32Health →
- Dapagliflozin at Point32Health →
- Dulaglutide at Point32Health →
- Dupilumab at Point32Health →
- Eculizumab at Point32Health →
- Elexacaftor Tezacaftor Ivacaftor at Point32Health →
- Empagliflozin at Point32Health →
- Erenumab at Point32Health →
- Evolocumab at Point32Health →
- Faricimab at Point32Health →
- Fingolimod at Point32Health →
- Fremanezumab at Point32Health →
- Galcanezumab at Point32Health →
- Glecaprevir Pibrentasvir at Point32Health →
- Guselkumab at Point32Health →
- Ibrutinib at Point32Health →
- Imatinib at Point32Health →
- Inclisiran at Point32Health →
- Infliximab at Point32Health →
- Ixekizumab at Point32Health →
- Lenalidomide at Point32Health →
- Liraglutide at Point32Health →
- Lisdexamfetamine at Point32Health →
- Mepolizumab at Point32Health →
- Methylphenidate at Point32Health →
- Naltrexone at Point32Health →
- Natalizumab at Point32Health →
- Nintedanib at Point32Health →
- Nivolumab at Point32Health →
- Nusinersen at Point32Health →
- Ocrelizumab at Point32Health →
- Ofatumumab at Point32Health →
- Omalizumab at Point32Health →
- Ozanimod at Point32Health →
- Palbociclib at Point32Health →
- Pembrolizumab at Point32Health →
- Pirfenidone at Point32Health →
- Ribociclib at Point32Health →
- Rimegepant at Point32Health →
- Risankizumab at Point32Health →
- Rituximab at Point32Health →
- Rivaroxaban at Point32Health →
- Sacubitril Valsartan at Point32Health →
- Secukinumab at Point32Health →
- Semaglutide at Point32Health →
- Sofosbuvir at Point32Health →
- Tafamidis at Point32Health →
- Tenofovir Alafenamide at Point32Health →
- Tezepelumab at Point32Health →
- Tirzepatide at Point32Health →
- Tofacitinib at Point32Health →
- Trastuzumab at Point32Health →
- Upadacitinib at Point32Health →
- Ustekinumab at Point32Health →
Generate a Point32Health PA packet
Open ApprovalHelp — generate a prior-auth packet tailored to Point32Health's criteria, with prescriber attestation and step-therapy documentation pre-filled.
Get started →Contact: hello@approvalhelp.com